Open Label, Balanced, Randomized, Two-treatment,Two-period,Single-dose, Cross-over Oral Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule With Prilosec OTCTM 20 mg Tablets in Healthy Human Adult Subjects, Under Fed Conditions.

Trial Profile

Open Label, Balanced, Randomized, Two-treatment,Two-period,Single-dose, Cross-over Oral Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule With Prilosec OTCTM 20 mg Tablets in Healthy Human Adult Subjects, Under Fed Conditions.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Jan 2010

At a glance

  • Drugs Omeprazole (Primary)
  • Indications Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Helicobacter pylori infections; Peptic ulcer; Zollinger-Ellison syndrome
  • Focus Pharmacokinetics
  • Most Recent Events

    • 16 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top